Results 1 to 10 of about 106,446 (312)
Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018 Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Elaine Ku +4 more
doaj +3 more sources
Angiotensin receptor blocker neprilysin inhibitors. [PDF]
World J Cardiol, 2021 Heart failure (HF) is a clinical syndrome that results from a structural or functional cardiac disorder that reduces the ability of the ventricle of the heart to fill with, or eject, blood. It is a multifaceted clinical condition that affects up to 2% of the population in the developed world, and is linked to significant morbidity and mortality; it is ...
Usuda D +18 more
europepmc +3 more sources
Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion
Indian Journal of Ophthalmology, 2020 Kanika Aggarwal +4 more
doaj +2 more sources
Angiotensin Receptor Blockers [PDF]
High Blood Pressure & Cardiovascular Prevention, 2003 Angiotensin receptor blockers (also known as ARBs) are a class of medications that are widely used by patients with high blood pressure, kidney disease, and heart failure. This article provides information for patients who receive this type of medication.
M Ruilope, Massimo Volpe
openaire +2 more sources
Angiotensin Ii Receptor Blockers [PDF]
Baylor University Medical Center Proceedings, 2003 The ARBs have very similar clinical profiles. They do, however, have different pharmacokinetic profiles, which may lead to some differences in efficacy. The newer agents irbesartan, candesartan, telmisartan, and olmesartan have longer half-lives and durations of action than the older agents losartan and valsartan (5).
Amy, Barreras, Cheryle, Gurk-Turner
openaire +2 more sources
Role of spironolactone in patients with resistant hypertension: A narrative review
Heart India, 2021 Treatment-resistant hypertension (RH) is defined as uncontrolled blood pressure (BP) despite use of at least three different antihypertensive agents (including angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, calcium channel ...
Geeta Sheth, Kavita Joshi
doaj +1 more source
Angiotensin receptor blockers (ARBs) [PDF]
Canadian Medical Association Journal, 2011 Guertin and colleagues describe potential savings from restricting use of ARBs in Canada.[1][1] The US Department of Veterans Affairs prefers angiotensin-converting-enzyme (ACE) inhibitors over ARBs, with national criteria for use to guide prescribing.
W. F. Gellad, C. B. Good
openaire +1 more source
Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts. [PDF]
, 2020 Background and objectives: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited.
Cho, Jaehyeong +10 more
core +2 more sources
Heliyon, 2023 Bisphenol-A (BPA) is a synthetic chemical compound broadly used in the plastic and epoxy resin industries with a considerable potential for food contamination. Literary reports have suggested that the altered renin-angiotensin system (RAS) is a mechanism
Ahmed A. Morsi +11 more
doaj +1 more source
Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure [PDF]
, 2018 Objectives: The purpose of this study was to evaluate the renal effects of sacubitril/valsartan in patients with heart failure and reduced ejection fraction.
Claggett, Brian +14 more
core +9 more sources